Endexx (OTC: EDXC), a provider of innovative hemp-derived cannabidiol (“CBD”) wellness and health products, today announced its receipt of a vendor number and cleared compliance with a major well-known drug chain for the placement of its BlessWell(TM) product line. Endexx has already begun the process of preparing products for shipment and placement by year-end into the national chain, and the initial arrangement will target approximately 1,000 stores in North America. The men’s skin care line, Blesswell, launched in May 2021 with famed record producer and music mogul, DJ Khaled. Blesswell has received high praise and mass exposure recently as many celebrity influencers have mentioned the product on social media. In addition, Chicago saw the successful launch of a large-scale, Blesswell pop-up store. Endexx’s goal for Blesswell is continued nationwide expansion, both in retail as well as barbershops.
To view the full press release, visit https://cnw.fm/bKy0A
About Endexx Corporation
Endexx, through its operating division CBD Unlimited Inc., develops and distributes all-natural CBD products derived from the cannabis sativa plant (hemp), containing less than 0.01% THC. Under its four major brands: CBD Unlimited, Phytobites, Maggie’s, and BlessWell, its products range from oils, capsules, topicals and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. PhytoBites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work to provide accuracy in dosage and delivery of optimal absorption per serving. For more information about the company, visit www.Endexx.com.
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.
